Envita Medical Centers
David C.
A patient story about choosing AAIT™ with more confidence
A longer patient story that adds emotion, context, and a clearer sense of what the treatment journey felt like from the patient side.
Watch this story aboveEnvita Medical Centers
AAIT™ treatment information and consultation
AAIT™ is a more advanced form of immunotherapy designed to target your specific cancer using your own immune cells and precision testing.
Featured testimonial
David C.
A longer patient story that adds emotion, context, and a clearer sense of what the treatment journey felt like from the patient side.
Why AAIT™ feels differentiated
Human-grade peptide training, longer expansion, and measured immune-cell quality.
Measured with flow cytometry
25+
Years treating cancer
Stage 3–4
Complex cancer focus
3-Step
Verified cell process
Free
Initial consultation
What Makes AAIT™ Different
Not all immunotherapy is the same. Standard approaches often activate the immune system broadly. AAIT™ is designed to be more targeted, more measurable, and more personalized—helping your immune system better recognize and respond to your specific cancer.
AAIT™ uses your own immune cells, creating an approach tailored to your biology rather than a one-size-fits-all treatment.
Cells are trained and expanded over time to help improve readiness before treatment—not rushed or generalized.
Cell quality is evaluated before treatment to help ensure viability and activity.
Why patients explore immunotherapy
Many patients begin researching more advanced immunotherapy options when standard treatments no longer feel sufficient.
A more personalized approach
AAIT™ begins with your own immune cells, which is why many patients see it as a more individualized form of immunotherapy.
Built around immune recognition
The goal is not simply to deliver cells, but to help the immune system better recognize and respond with greater specificity.
More measured than generic messaging
Training, expansion, and verification create a more structured process than broad promises about immunotherapy alone.
Designed for patients seeking next-step options
For patients researching immunotherapy, AAIT™ can represent a more forward-looking option when they want something more tailored and better explained.
How AAIT™ Works
Your immune cells are collected under clinical supervision as the foundation for a more individualized approach.
Cells are trained using peptides and expanded over time to help improve targeting and response.
Cell quality is measured before delivery, including viability and activity.
What gets measured
The technology matters because it helps answer a simple patient question: how do you know what is being prepared before treatment?
Cell count
Viability
Cytotoxic activity
Sterility
How AAIT™ compares
Many patients don't realize how much immunotherapy approaches can vary until they ask the right questions.
At-a-glance filter
If a provider cannot clearly explain how the cells are trained, grown, and verified, it becomes harder to know what you are really buying.
Envita / AAIT™
Specified before treatment
Typical provider
Details can vary and may stay broad
Cell training
Envita / AAIT™
Human-grade peptides are used to educate and prepare immune cells for a more targeted response.
Typical provider
Training method may be described broadly or not specified upfront.
Growth window
Envita / AAIT™
Cells are expanded over 25+ days before treatment—giving them time to develop.
Typical provider
Expansion time may be shorter or left unclear.
Quality check
Envita / AAIT™
Cell count, viability, and activity are measured before delivery—not just described.
Typical provider
Discussion may focus on cell delivery without the same measurement detail.
What the patient can ask for
Envita / AAIT™
Specific process checkpoints that can be discussed and reviewed before treatment.
Typical provider
Answers may stay general, making comparisons harder.
Questions to Ask
If these answers are unclear, it can be harder to understand what you are receiving.
Patient stories
Hear from patients who explored more personalized immunotherapy options and chose AAIT™.
Envita Medical Centers
A patient story about choosing AAIT™ with more confidence
A longer patient story that adds emotion, context, and a clearer sense of what the treatment journey felt like from the patient side.
Watch this story aboveEnvita Medical Centers
A patient case focused on tongue and throat cancer care
A landscape patient case video that gives visitors a clearer second perspective on how Envita approaches tongue and throat cancer care.
Watch this story aboveCommon questions
Patient fit
AAIT™ may be considered for patients who:
Next step
Speak with a specialist to review your case and explore whether this approach may be appropriate for you.